Department of Obstetrics and Gynaecology

Berlin, 16.08.2017 250th Statement of the German Society of Gynecology and Obstetrics e. V. for the Modification of the Cancer Awareness Guidelines (KFE-RL) Mammography Screening: Letters of invitation and decision-making as well as other Changes in Section III B of the CRCD (2017) Seelbach-Goebel B, Beckmann M Journal article Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study (2017) Trapp E, Steidl J, Rack B, Kupka MS, Andergassen U, Jueckstock J, Kurt A, et al. Journal article Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (2017) Glubb DM, Johnatty SE, Quinn MCJ, O'Mara TA, Tyrer JP, Gao B, Fasching P, et al. Journal article Berlin, 17.02.2017 244th Statement of the German Society of Gynecology and Obstetrics e. V. for the Modification of Children's RiLi until the Age of 6: Examination Book for Children for Extended Neonatal Screening and Screening for Cystic Fibrosis (2017) Seelbach-Goebel B, Beckmann M Journal article Berlin, 27.01.2017 242nd Statement of the German Society for Gynecology and Obstetrics e. V. in cooperation with the Professional Association of Gynecologists e. V. Amending the DMP - A - RL: Supplement to Annex 3 (DMP Breast Cancer) and Appendix 4 (Breast Cancer Documentation) (2017) Seelbach-Goebel B, Beckmann MW, Beckmann M Journal article A phase III, open label, randomized multicenter controlled trial of oral versus intravenous treosulfan in heavily pretreated recurrent ovarian cancer: a study of the North-Eastern German Society of Gynecological Oncology (NOGGO) (2017) Sehouli J, Tome O, Dimitrova D, Camara O, Runnebaum IB, Tessen HW, Rautenberg B, et al. Journal article Can contemporary trials in HER2-negative metastatic breast cancer (mBC) detect overall survival (OS) benefit? (2017) Kuemmel S, Jackisch C, Mueller V, Schneeweiss A, Klawitter S, Lux MP Conference contribution Comparative budget impact assessment of the different breast cancer genomic tests in Germany (2017) Lux MP, Schrauder MG, Hildebrandt T, Nabieva N, Kuemmel S, Blohmer JU Conference contribution A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study (2017) Harbeck N, Saupe S, Jaeger E, Schmidt M, Kreienberg R, Mueller L, Otremba BJ, et al. Journal article Antioxidant effect of aqueous extract of four plants with therapeutic potential on gynecological diseases; Semen persicae, Leonurus cardiaca, Hedyotis diffusa, and Curcuma zedoaria (2017) Ji S, Fattahi A, Raffel N, Hoffmann I, Beckmann M, Dittrich R, Schrauder MG Journal article